Tehran University of Medical Sciences

Science Communicator Platform

Share By
Prognostic Value of Albumin-Bilirubin (Albi) Grade in Patients With Gastric Cancer: A Systematic Review and Meta-Analysis Publisher Pubmed



Omourikharashtomi M ; Ghoshouni H ; Ayati Firoozabadi A ; Mahdizadeh F ; Anushiravani A
Authors

Source: Journal of Gastrointestinal Cancer Published:2026


Abstract

Background: Gastric cancer (GC) is considered a leading cause of cancer-related deaths. Identifying patients with poor survival outcomes and factors related to prognosis are crucial measures in patient care. In addition to the existing prognostic markers, new markers need to be introduced to overcome their limitations and improve risk stratification. In this systematic review and meta-analysis, we aim to assess the albumin-bilirubin (ALBI) grade as a novel prognostic marker in patients with GC. Method: The PubMed, Web of Science, Embase, and Scopus databases were searched from inception to April 4, 2025. Studies investigating the prognostic value of the ALBI grade in GC were included. The prognostic efficacy was evaluated using hazard ratio (HR) with 95% confidence interval (95% CI). The meta-analysis was performed using R version 4.5.1. Result: The meta-analysis included 3,459 patients in the univariate analysis for overall survival (OS) and 2,503 in the multivariate analysis. A higher ALBI grade was associated with worse OS in both univariate (HR = 3.05; 95%CI, 1.74–5.33; P ˂ 0.0001) and multivariate analyses (HR = 1.89; 95%CI, 1.30–2.76; P = 0.0010). A meta-analysis of 888 patients also showed that a higher ALBI grade was associated with worse recurrence-free survival/disease-free survival (RFS/DFS) in both univariate (HR = 2.23; 95%CI, 1.74–2.85; P ˂ 0.0001) and multivariate analyses (HR = 1.86; 95%CI, 1.42–2.43; P ˂ 0.0001). Conclusion: A higher ALBI grade is associated with worse OS and RFS/DFS. This novel marker could be used to complement the existing prognostic markers and enhance survival prediction in patients with GC. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2026.
Related Docs
View other Related Docs
1. Prognostic Value of Albumin-Bilirubin Grade in Patients With Pancreatic Cancer: A Systematic Review and Meta-Analysis, Indian Journal of Gastroenterology (2026)
2. Prognostic Value of Nlr, Plr, Sii, and Dnlr in Urothelial Bladder Cancer Following Radical Cystectomy, Clinical Genitourinary Cancer (2024)
3. Exploring the Potential of Machine Learning in Gastric Cancer: Prognostic Biomarkers, Subtyping, and Stratification, BMC Cancer (2025)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Mansournia (2)
Hossein Zabihi Mahmoudabadi (1)
Other Related Docs
4. Relationship Between Demographic and Pathological Characteristics on the 5-Year Survival Rate of Gastric Cancer Patients in Tehran Province, Tehran University Medical Journal (2022)
5. Sex-Based Differences in Survival After Liver Transplantation for Colorectal Cancer Liver Metastases: A Multivariable Analysis, JHEP Reports (2025)
6. Survival Analysing of the Breast Cancer Patients Using Cure Model, Iranian Red Crescent Medical Journal (2017)
7. Influential Factors on Survival in Gastric Cancer: A Single-Center Study, Journal of Research in Medical Sciences (2022)
8. The Value and Limitations of Urothelial Bladder Carcinoma Molecular Classifications to Predict Oncological Outcomes and Cancer Treatment Response: A Systematic Review and Meta-Analysis, Urologic Oncology: Seminars and Original Investigations (2021)
9. Survival Rate in Hepatocellular Carcinoma After Surgery and Its Association With Clinicopathological Factors: A Single-Center Report, Middle East Journal of Digestive Diseases (2025)
10. Clinicopathological and Prognostic Value of Lncrna Pandar Expression in Solid Tumors: Evidence From a Systematic Review and Meta-Analysis, Journal of Cellular Physiology (2019)
11. Treatment Outcomes and Survival Analysis of Pediatric Mature B-Cell Non-Hodgkin Lymphoma: A Retrospective Study Comparing Lmb96 and R-Chop Regimens, Leukemia Research Reports (2025)
12. Benchmarking the Real-World Transplant Benefit in Unresectable Colorectal Liver Metastases: A Preliminary External Validity Assessment of the Transmet Trial, Liver Transplantation (2026)
13. Unveiling Recurrence Patterns: Analyzing Predictive Risk Factors for Breast Cancer Recurrence After Surgery, Cancer Informatics (2024)
14. Machine Learning-Based Models for Prediction of Survival in Medulloblastoma: A Systematic Review and Meta-Analysis, Neurological Sciences (2025)
15. Axillary Staging in Post-Neoadjuvant Chemotherapy Breast Cancer Patients: Prognostic Analysis and Validation of Axillary Nodal Metrics and Comparison of the Pathological Node Staging Versus the Lymph Node Ratio Systems in a 169-Case Series, BMC Cancer (2026)
16. Construction of a Stromal-Related Prognostic Model in Acute Myeloid Leukemia by Comprehensive Bioinformatics Analysis, Current Research in Translational Medicine (2025)
17. Prognostic Value of Anion Gap for Patients With Heart Failure: A Systematic Review and Meta-Analysis, BMC Cardiovascular Disorders (2024)
18. Prognostic Significance of Tumor-Stroma Ratio in Hepatocellular and Gallbladder Carcinomas: A Systematic Review and Meta-Analysis, Asian Pacific Journal of Cancer Biology (2025)
19. Predictors of Survival for Locally Advanced Rectal Cancer Patients With Poor Response to Neoadjuvant Chemoradiotherapy, Radiation Oncology (2026)
20. Assessment of the Fitness of Cox and Parametric Regression Models of Survival Distribution for Iranian Breast Cancer Patients' Data, Journal of Advanced Pharmaceutical Technology and Research (2019)